USANA HEALTH SCIENCES, INC. Contract Liability (Deferred Revenue)
USANA HEALTH SCIENCES, INC. (USNA) had Contract Liability (Deferred Revenue) of $10.64 million as of 2026-01-03, per its 10-K filed 2026-03-16.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-03-16
- 2026-01-03: Contract with Customer, Liability, Current $10.64M.
- 2024-12-28: Contract with Customer, Liability, Current $12.05M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-01-03 | $10.64M 10-K · filed 2026-03-16 |
| 2024-12-28 | $12.05M 10-K · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |